CV Protection in the EMPA-REG OUTCOME Trial: A ... - Diabetes Care
Jun 11, 2016 · (38%), hospitalization for heart failure (35%), and death from any cause (32%) observed in the EMPA-REG OUTCOME trial using an inhibitor of ...
Address
Tel
Website
Date
|
Product Description
|
Supplier
|
Money
|
Quantity
|
Weight
|
---|
nutricionendiabetes's website is nutricionendiabetes.com.ar